13 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
POLYMER COATED POWDER FREE NITRILE EXAMINATION GLOVES (BLUE,WHITE,VIOLET, PINK,GREEN)
FDA 510(k)
FDA Class 1
·General Hospital
Medline Industries, Inc.
FDA UDI
MEDLINE INDUSTRIES, INC.·10080196983902·HYPERINFLATION SYSTEM
Implant-One
FDA UDI
Implant Logistics, Inc.·D762APT0505300·Abutment, 500 Series Angled Post .5mm Cuff Heig...
BELLEGLASS HP ENAMEL
FDA 510(k)
FDA Class 2
·Dental
GEO STRUCTURE
FDA 510(k)
FDA Class 2
·Orthopedic
Widex
FDA UDI
Widex A/S·05706069687118·Widex EVOKE E-IM (Clay brown ) 330, Left
Widex
FDA UDI
Widex A/S·05706069687125·Widex EVOKE E-IM (Dark brown ) 330, Left
Widex
FDA UDI
Widex A/S·05706069687101·Widex EVOKE E-IM (Light beige ) 330, Left
COSYCOT INFANT WARMER
FDA Adverse Event
Malfunction
·FISHER & PAYKEL HEALTHCARE, LTD.·Product code FMT·May 5, 2008
ITRAK 3500
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS(SLC)·Product code LLZ·April 8, 2013
HEARTSTART MRX - EMS DEFIBRILLATOR
FDA Adverse Event
Malfunction
·PHILIPS HEALTHCARE·Product code MKJ·April 5, 2011
TENDRIL SDX
FDA Adverse Event
Injury
·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code DTB·May 27, 2008
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014